1. News

CENTOGENE extends its test portfolio

CENTOGENE has recently added numerous single gene tests and next generation sequencing (NGS) panels to its portfolio. Our NGS panel compositions always reflect the clinical relevance to the specific disease phenotype, transforming genetic data into actionable medical decisions.

All newly added single genes and NGS panels at a glance

Contact Us

International Communication Manager anne-marie.neumann@centogene.com

Subscribe to our Newsletter